Leptanal Stungulyf, lausn 50 míkróg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

leptanal stungulyf, lausn 50 míkróg/ml

piramal critical care b.v. - fentanylum cítrat - stungulyf, lausn - 50 míkróg/ml

Briumvi Evrópusambandið - íslenska - EMA (European Medicines Agency)

briumvi

neuraxpharm pharmaceuticals s.l. - ublituximab - multiple sclerosis, relapsing-remitting; multiple sclerosis - Ónæmisbælandi lyf - briumvi is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features.

Adempas Evrópusambandið - íslenska - EMA (European Medicines Agency)

adempas

bayer ag - riociguat - háþrýstingur, lungnabólga - blóðþrýstingslækkandi lyf fyrir lungnaháþrýsting - chronic thromboembolic pulmonary hypertension (cteph)adempas is indicated for the treatment of adult patients with who functional class (fc) ii to iii withinoperable cteph,persistent or recurrent cteph after surgical treatment,to improve exercise capacity. pulmonary arterial hypertension (pah)adultsadempas, as monotherapy or in combination with endothelin receptor antagonists, is indicated for the treatment of adult patients with pulmonary arterial hypertension (pah) with who functional class (fc) ii to iii to improve exercise capacity. verkun hefur verið sýnt fram í pah íbúa þar á meðal orsökum sjálfvakin eða arfgengum pah eða pah tengslum við tengdum vef sjúkdómur. paediatricsadempas is indicated for the treatment of pah in paediatric patients aged less than 18 years of age and body weight ≥ 50 kg with who functional class (fc) ii to iii in combination with endothelin receptor antagonists.